Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

AZD9291 in EGFR exon 20 insertion mutations

Trial Profile

AZD9291 in EGFR exon 20 insertion mutations

Status: Completed
Phase of Trial: Phase I/II

Latest Information Update: 11 Feb 2022

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Osimertinib (Primary)
  • Indications Non-small cell lung cancer
  • Focus Therapeutic Use
  • Acronyms AEX20
  • Most Recent Events

    • 06 May 2021 Status changed from active, no longer recruiting to completed.
    • 10 Apr 2021 Results (n=12; Feb 2020) assessing efficacy in patients enrolled in stage 1 of this trial presented at the 112th Annual Meeting of the American Association for Cancer Research
    • 28 Sep 2020 Planned End Date changed from 31 May 2021 to 31 Dec 2020.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top